Results 41 to 50 of about 85,679 (96)

Comparative Effects of GLP-1 and GLP-2 on Beta-Cell Function, Glucose Homeostasis and Appetite Regulation

Biomolecules
Glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) are related intestinal L-cell derived secretory products. GLP-1 has been extensively studied in terms of its influence on metabolism, but less attention has been devoted to GLP-2 in this
Asif Ali, Dawood Khan, Vaibhav Dubey, Andrei I. Tarasov, Peter R. Flatt, Nigel Irwin   +5 more
doaj   +1 more source

Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto′s thyroiditis

Journal of Research in Medical Sciences, 2015
Background: The influence of Hashimoto′s thyroiditis (HT) with subclinical hypothyroidism or euthyroid status on the alteration of glucagon-like peptide (GLP)-1 and GLP-2 levels remains uncertain.
Yue Jin, Hong Liu, Shao-Gang Ma, Jian-Ping Cheng, Kai Zhang   +4 more
doaj  

Poster 6: GLP-1 Receptor Agonist Use Is Not Associated With an Increased Risk of Complications After Anatomic Total Shoulder Arthroplasty

Orthopaedic Journal of Sports Medicine
Objectives: Glucagon-like-peptide-1 (GLP-1) agonists, also known as GLP-1 receptor agonists (GLP-1 RAs), incretin mimetics, or GLP-1 analogs are a class of medications that have surged in popularity since their approval.
Arsen M. Omurzakov BA, Arsen M. Omurzakov BA, Aakash Shah, David C. Kaelber, John M. Apostolakos   +4 more
doaj   +1 more source

Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential

Toxicology Reports
Glucagon (GCG) like peptide 1 (GLP-1) has emerged as a powerful player in regulating metabolism and a promising therapeutic target for various chronic diseases.
Tohada M. AL-Noshokaty, Rehab Abdelhamid, Nourhan M. Abdelmaksoud, Aya Khaled, Mariam Hossam, Razan Ahmed, Toka Saber, Shahd Khaled, Shereen Saeid Elshaer, Ahmed I. Abulsoud   +9 more
doaj   +1 more source

Cardioprotective effects of GLP‐1(28‐36a): A degraded metabolite or GLP‐1’s better half?

Journal of Diabetes Investigation, 2020
Yangyang Liu, Sodai Kubota, Katsumi Iizuka, Daisuke Yabe   +3 more
doaj   +1 more source

GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series

BMJ Open Diabetes Research & Care
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and dual glucose insulinotropic polypeptide (GIP)/GLP-1 RA are widely prescribed, but their effectiveness in different subtypes of maturity-onset diabetes of the young (MODY) is unknown ...
William H Herman, Elif A Oral, Rochelle N Naylor, Brigid Gregg, Alina Z Mehdi, Lily Deng, Colby L Chase, Maria Cristina Foss-Freitas, Mansa Krishnamurthy, David T Broome   +9 more
doaj   +1 more source

Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review

Neurology and Therapy
Introduction Glucagon-like peptide-1 (GLP-1) is an incretin hormone that modulates glucose metabolism and insulin secretion. Recent translational and clinical research has evaluated the effects of GLP-1 receptor agonists (GLP-1 RAs), a class of drugs ...
Juliana West, Maggie Li, Sabrina Wong, Gia Han Le, Kayla M. Teopiz, Kyle Valentino, Christine E. Dri, Roger S. McIntyre   +7 more
doaj   +1 more source

Revolutionizing disease treatment through bioengineered probiotics and glucagon‐like peptide 1 (GLP‐1) based strategies: A path towards effective cures

Food Bioengineering
Human intestinal gut microbiota harbors complex and diverse microbes that play an important role in maintaining the homeostasis of the intestinal microenvironment in humans.
Smriti Jain, Adarsh Kumar Shukla, Deepika, Surbhi Panwar, Anita Kumari, Ashok Kumar Yadav, Ashwani Kumar   +6 more
doaj   +1 more source

Foods as Modulators of GLP-1 Secretion. [PDF]

Nutrients
Tkaczenko H, Kołodziejska R, Rymuszka A, Kamiński P, Kurhaluk N.   +4 more
europepmc   +1 more source

GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application. [PDF]

Int J Mol Sci
Myśliwczyk D, Myśliwiec M, Minarowska A, Wasilewska E.   +3 more
europepmc   +1 more source